. (2016). Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse. Progress In Neuro-Psychopharmacology & Biological Psychiatry, 65, 269-87. https://doi.org/10.1016/j.pnpbp.2015.11.004 (Original work published 2016)
SE Maggio
First name:
SE
Last name:
Maggio
. (2018). Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats. Psychopharmacology, 235(5), 1439-1453. https://doi.org/10.1007/s00213-018-4853-4
. (2018). An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI. Drug And Alcohol Dependence, 193, 154-161. https://doi.org/10.1016/j.drugalcdep.2018.09.008 (Original work published 2018)
. (2020). Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats. Drug And Alcohol Dependence, 212, 107988. https://doi.org/10.1016/j.drugalcdep.2020.107988 (Original work published 2020)
. (2022). Effects of adolescent alcohol exposure via oral gavage on adult alcohol drinking and co-use of alcohol and nicotine in Sprague Dawley rats. Drug And Alcohol Dependence, 232, 109298. https://doi.org/10.1016/j.drugalcdep.2022.109298 (Original work published 2022)
